ArticleMolecular and clinical oncology2015

Prognostic outcome in patients treated with tyrosine kinase inhibitors as first-line molecular-targeted therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in Japan.

Akira Miyazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.